首页|Collaborations Pharmaceuticals Reports Findings in Machine Learning (Sequential Contrastive and Deep Learning Models to Identify Selective Butyrylcholinesterase Inhibitors)
Collaborations Pharmaceuticals Reports Findings in Machine Learning (Sequential Contrastive and Deep Learning Models to Identify Selective Butyrylcholinesterase Inhibitors)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Machine Learning is th e subject of a report. According to newsreporting originating from Raleigh, Nor th Carolina, by NewsRx correspondents, research stated, “Butyrylcholinesterase( BChE) is a target of interest in late-stage Alzheimer’s Disease (AD) where selec tive BChEinhibitors (BIs) may offer symptomatic treatment without the harsh sid e effects of acetylcholinesterase(AChE) inhibitors. In this study, we explore m ultiple machine learning strategies to identify BIs , optimizingfor precision o ver all other metrics.”
RaleighNorth CarolinaUnited StatesNorth and Central AmericaBusinessButyrylcholinesteraseCholinesterasesCyb orgsEmerging TechnologiesEnzymes and CoenzymesHydrolasesMachine Learning
NETL
NSTL
